APA

Patel M. V., Kolasa T., Mortell K., Matulenko M. A., Hakeem A. A., Rohde J. J., Nelson S. L., Cowart M. D., Nakane M., Miller L. N., Uchic M. E., Terranova M. A., El-Kouhen O. F., Donnelly-Roberts D. L., Namovic M. T., Hollingsworth P. R., Chang R., Martino B. R., Wetter J. M., Marsh K. C., Martin R., Darbyshire J. F., Gintant G., Hsieh G. C., Moreland R. B., Sullivan J. P., Brioni J. D. & Stewart A. O. (20070223). Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction. : Journal of medicinal chemistry.

Chicago

Patel Meena V, Kolasa Teodozyj, Mortell Kathleen, Matulenko Mark A, Hakeem Ahmed A, Rohde Jeffrey J, Nelson Sherry L, Cowart Marlon D, Nakane Masaki, Miller Loan N, Uchic Marie E, Terranova Marc A, El-Kouhen Odile F, Donnelly-Roberts Diana L, Namovic Marian T, Hollingsworth Peter R, Chang Renjie, Martino Brenda R, Wetter Jill M, Marsh Kennan C, Martin Ruth, Darbyshire John F, Gintant Gary, Hsieh Gin C, Moreland Robert B, Sullivan James P, Brioni Jorge D and Stewart Andrew O. 20070223. Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction. : Journal of medicinal chemistry.

Harvard

Patel M. V., Kolasa T., Mortell K., Matulenko M. A., Hakeem A. A., Rohde J. J., Nelson S. L., Cowart M. D., Nakane M., Miller L. N., Uchic M. E., Terranova M. A., El-Kouhen O. F., Donnelly-Roberts D. L., Namovic M. T., Hollingsworth P. R., Chang R., Martino B. R., Wetter J. M., Marsh K. C., Martin R., Darbyshire J. F., Gintant G., Hsieh G. C., Moreland R. B., Sullivan J. P., Brioni J. D. and Stewart A. O. (20070223). Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction. : Journal of medicinal chemistry.

MLA

Patel Meena V, Kolasa Teodozyj, Mortell Kathleen, Matulenko Mark A, Hakeem Ahmed A, Rohde Jeffrey J, Nelson Sherry L, Cowart Marlon D, Nakane Masaki, Miller Loan N, Uchic Marie E, Terranova Marc A, El-Kouhen Odile F, Donnelly-Roberts Diana L, Namovic Marian T, Hollingsworth Peter R, Chang Renjie, Martino Brenda R, Wetter Jill M, Marsh Kennan C, Martin Ruth, Darbyshire John F, Gintant Gary, Hsieh Gin C, Moreland Robert B, Sullivan James P, Brioni Jorge D and Stewart Andrew O. Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction. : Journal of medicinal chemistry. 20070223.